AVXT

AVAX Technologies, Inc.
Exchange: Nasdaq
Intends to acquire rights to, and to develop, technologies and products for the treatment of cancer and other life-threatening diseases, primarily focusing on development of immunotherapies and chemotherapies for cancer.